{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T17:32:18Z","timestamp":1663695138541},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"14","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s15006-018-0022-2","type":"journal-article","created":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T09:20:16Z","timestamp":1534152016000},"page":"52-61","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Das akute Koronarsyndrom"],"prefix":"10.1007","volume":"160","author":[{"given":"Johannes","family":"Leschik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timm","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"22_CR1","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1161\/CIRCULATIONAHA.115.018931","volume":"133","author":"A. Hartley","year":"2016","unstructured":"Hartley A, Marshall DC, Salciccioli JD et al. Trends in Mortality From Ischemic Heart Disease and Cerebrovascular Disease in Europe: 1980 to 2009. Circulation. 2016;133:1916\u201326","journal-title":"Circulation"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"3232","DOI":"10.1093\/eurheartj\/ehw334","volume":"37","author":"N. Townsend","year":"2016","unstructured":"Townsend N, Wilson L, Bhatnagar P et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37:3232\u201345","journal-title":"Eur Heart J"},{"key":"22_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/eurheartj\/ehv598","volume":"37","author":"V. Regitz-Zagrosek","year":"2016","unstructured":"Group EUCCS, Regitz-Zagrosek V, Oertelt-Prigione S et al. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37:24\u201334","journal-title":"Eur Heart J"},{"key":"22_CR4","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/circ.54.3.947585","volume":"54","author":"L. Campeau","year":"1976","unstructured":"Campeau L. Letter: Grading of angina pectoris. Circulation. 1976;54:522\u20133","journal-title":"Circulation"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0002-9149(02)02463-3","volume":"90","author":"J.G. Canto","year":"2002","unstructured":"Canto JG, Fincher C, Kiefe CI et al. Atypical presentations among Medicare beneficiaries with unstable angina pectoris. Am J Cardiol. 2002;90:248\u201353","journal-title":"Am J Cardiol"},{"key":"22_CR6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1378\/chest.126.2.461","volume":"126","author":"D. Brieger","year":"2004","unstructured":"Brieger D, Eagle KA, Goodman SG et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest. 2004;126:461\u20139","journal-title":"Chest"},{"key":"22_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"M. Roffi","year":"2016","unstructured":"Roffi M, Patrono C, Collet JP et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267\u2013315","journal-title":"Eur Heart J"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1093\/eurheartj\/ehr358","volume":"32","author":"M.H. Mackay","year":"2011","unstructured":"Mackay MH, Ratner PA, Johnson JL et al. Gender differences in symptoms of myocardial ischaemia. Eur Heart J. 2011;32:3107\u201314","journal-title":"Eur Heart J"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B. Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119\u201377","journal-title":"Eur Heart J"},{"key":"22_CR10","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jacc.2015.08.865","volume":"66","author":"S. Khera","year":"2015","unstructured":"Khera S, Kolte D, Gupta T et al. Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States. J Am Coll Cardiol. 2015;66:1961\u201372","journal-title":"J Am Coll Cardiol"},{"key":"22_CR11","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/2012.jama.11348","volume":"308","author":"E. Puymirat","year":"2012","unstructured":"Puymirat E, Simon T, Steg PG et al. Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction. JAMA. 2012;308:998\u20131006","journal-title":"JAMA"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/europace\/euu208","volume":"16","author":"B. Gorenek","year":"2014","unstructured":"Gorenek B, Blomstrom Lundqvist C, Brugada Terradellas J et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace. 2014;16:1655\u201373","journal-title":"Europace"},{"key":"22_CR13","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","volume":"377","author":"H. Thiele","year":"2017","unstructured":"Thiele H, Akin I, Sandri M et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017;377:2419\u201332","journal-title":"N Engl J Med"},{"key":"22_CR14","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/eurheartj\/ehp492","volume":"31","author":"P. Widimsky","year":"2010","unstructured":"Widimsky P, Wijns W, Fajadet J et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J. 2010;31:943\u201357","journal-title":"Eur Heart J"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1016\/j.jcin.2012.07.013","volume":"5","author":"A.W. Chan","year":"2012","unstructured":"Chan AW, Kornder J, Elliott H et al. Improved survival associated with pre-hospital triage strategy in a large regional ST-segment elevation myocardial infarction program. JACC Cardiovasc Interv. 2012;5:1239\u201346","journal-title":"JACC Cardiovasc Interv"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1056\/NEJMoa1301092","volume":"368","author":"P.W. Armstrong","year":"2013","unstructured":"Armstrong PW, Gershlick AH, Goldstein P et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368:1379\u201387","journal-title":"N Engl J Med"},{"key":"22_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/eurheartj\/ehi810","volume":"27","author":"E. Boersma","year":"2006","unstructured":"Boersma E, Primary Coronary Angioplasty vs. Thrombolysis G. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006;27:779\u201388","journal-title":"Eur Heart J"},{"key":"22_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.jcin.2012.04.012","volume":"5","author":"K.H. Scholz","year":"2012","unstructured":"Scholz KH, Maier SK, Jung J et al. Reduction in treatment times through formalized data feedback: results from a prospective multicenter study of ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2012;5:848\u201357","journal-title":"JACC Cardiovasc Interv"},{"key":"22_CR19","first-page":"299","volume":"5","author":"J. Knot","year":"2009","unstructured":"Knot J, Widimsky P, Wijns W et al. How to set up an effective national primary angioplasty network: lessons learned from five European countries. EuroIntervention. 2009;5:299\u2013309","journal-title":"EuroIntervention"},{"key":"22_CR20","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","volume":"385","author":"M. Valgimigli","year":"2015","unstructured":"Valgimigli M, Gagnor A, Calabro P et al. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet. 2015;385:2465\u201376","journal-title":"Lancet"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1093\/eurheartj\/ehm402","volume":"28","author":"A. Kastrati","year":"2007","unstructured":"Kastrati A, Dibra A, Spaulding C et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28:2706\u201313","journal-title":"Eur Heart J"},{"key":"22_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.amjcard.2004.09.014","volume":"95","author":"A.I. Larsen","year":"2005","unstructured":"Larsen AI, Galbraith PD, Ghali WA et al. Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol. 2005;95:261\u20133","journal-title":"Am J Cardiol"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/ehjci\/jeu210","volume":"16","author":"P. Lancellotti","year":"2015","unstructured":"Lancellotti P, Price S, Edvardsen T et al. The use of echocardiography in acute cardiovascular care: recommendations of the European Association of Cardiovascular Imaging and the Acute Cardiovascular Care Association. Eur Heart J Cardiovasc Imaging. 2015;16:119\u201346","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"22_CR24","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","volume":"360","author":"S.R. Mehta","year":"2009","unstructured":"Mehta SR, Granger CB, Boden WE et al. Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med. 2009;360:2165\u201375","journal-title":"N Engl J Med"},{"key":"22_CR25","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1093\/eurheartj\/ehr418","volume":"33","author":"H. Thiele","year":"2012","unstructured":"Thiele H, Rach J, Klein N et al. Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI Trial). Eur Heart J. 2012;33:2035\u201343","journal-title":"Eur Heart J"},{"key":"22_CR26","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","volume":"163","author":"C.B. Granger","year":"2003","unstructured":"Granger CB, Goldberg RJ, Dabbous O et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163:2345\u201353","journal-title":"Arch Intern Med"},{"key":"22_CR27","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ahj.2012.12.020","volume":"165","author":"B. Bawamia","year":"2013","unstructured":"Bawamia B, Mehran R, Qiu W et al. Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review. Am Heart J.2013;165:441\u201350","journal-title":"Am Heart J"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM198810273191701","volume":"319","author":"P. Theroux","year":"1988","unstructured":"Theroux P, Ouimet H, McCans J et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med. 1988;319:1105\u201311","journal-title":"N Engl J Med"},{"key":"22_CR29","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa050522","volume":"352","author":"M.S. Sabatine","year":"2005","unstructured":"Sabatine MS, Cannon CP, Gibson CM et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med. 2005;352:1179\u201389","journal-title":"N Engl J Med"},{"key":"22_CR30","doi-asserted-by":"publisher","first-page":":363","DOI":"10.1177\/2048872614534078","volume":"3","author":"S. Servi De","year":"2014","unstructured":"De Servi S, Goedicke J, Schirmer A et al. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial. Eur Heart J Acute Cardiovasc Care. 2014;3:363\u201372","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"22_CR31","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/eurheartj\/ehu160","volume":"35","author":"D. Lindholm","year":"2014","unstructured":"Lindholm D, Varenhorst C, Cannon CP et al. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial. Eur Heart J. 2014;35:2083\u201393","journal-title":"Eur Heart J"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/eurheartj\/ehv531","volume":"37","author":"M.P. Bonaca","year":"2016","unstructured":"Bonaca MP, Bhatt DL, Steg PG et al. Ischaemic risk and efficacy of ticagrelor in relation to time from P2Y12 inhibitor withdrawal in patients with prior myocardial infarction: insights from PEGASUS-TIMI 54. Eur Heart J. 2016;37:1133\u201342","journal-title":"Eur Heart J"},{"key":"22_CR33","doi-asserted-by":"publisher","first-page":"e002524","DOI":"10.1161\/JAHA.115.002524","volume":"4","author":"F. Costa","year":"2015","unstructured":"Costa F, Tijssen JG, Ariotti S et al. Incremental Value of the CRUSADE, ACUITY, and HAS-BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short Duration of Dual Antiplatelet Therapy. J Am Heart Assoc. 2015;4:e002524","journal-title":"J Am Heart Assoc"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"670S","DOI":"10.1378\/chest.08-0691","volume":"133","author":"R.A. Harrington","year":"2008","unstructured":"Harrington RA, Becker RC, Cannon CP et al. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:670S\u2013707S","journal-title":"Chest"},{"key":"22_CR35","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1136\/bmj.e553","volume":"344","author":"J. Silvain","year":"2012","unstructured":"Silvain J, Beygui F, Barthelemy O et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2012;344:e553","journal-title":"BMJ"},{"key":"22_CR36","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","volume":"295","author":"S. Yusuf","year":"2006","unstructured":"Yusuf S, Mehta SR, Chrolavicius S et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. JAMA. 2006;295:1519\u201330","journal-title":"JAMA"},{"key":"22_CR37","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M. Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213\u201360","journal-title":"Eur Heart J"},{"key":"22_CR38","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","volume":"127","author":"A.L. Dans","year":"2013","unstructured":"Dans AL, Connolly SJ, Wallentin L et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation. 2013;127:634\u201340","journal-title":"Circulation"},{"key":"22_CR39","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1056\/NEJMoa1611594","volume":"375","author":"C.M. Gibson","year":"2016","unstructured":"Gibson CM, Mehran R, Bode C et al. Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016;375:2423\u201334","journal-title":"N Engl J Med"},{"key":"22_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1161\/CIRCULATIONAHA.109.891523","volume":"121","author":"C.K. Chow","year":"2010","unstructured":"Chow CK, Jolly S, Rao-Melacini P et al. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010;121:750\u20138","journal-title":"Circulation"},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1056\/NEJMoa050461","volume":"352","author":"J.C. LaRosa","year":"2005","unstructured":"LaRosa JC, Grundy SM, Waters DD et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425\u201335","journal-title":"N Engl J Med"},{"key":"22_CR42","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"C.P. Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes. N Engl J Med. 2015;372:2387\u201397","journal-title":"N Engl J Med"},{"key":"22_CR43","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","volume":"376","author":"M.S. Sabatine","year":"2017","unstructured":"Sabatine MS, Giugliano RP, Keech AC et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease. N Engl J Med. 2017;376:1713\u201322","journal-title":"N Engl J Med"},{"key":"22_CR44","unstructured":"Schwartz GG, Szarek M, Bhatt DL. Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab - ODYSSEY OUTCOMES. \n                    http:\/\/www.acc.org\/latest-in-cardiology\/clinical-trials\/2018\/03\/09\/08\/02\/odyssey-outcomes\n                    \n                  ; zuletzt besucht: 2.7.2018"},{"key":"22_CR45","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"L. Ryden","year":"2013","unstructured":"Authors\/Task Force M, Ryden L, Grant PJ et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035\u201387","journal-title":"Eur Heart J"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-018-0022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-018-0022-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-018-0022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T10:33:32Z","timestamp":1600857212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-018-0022-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":45,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["22"],"URL":"https:\/\/doi.org\/10.1007\/s15006-018-0022-2","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"13 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}